Steven Goldby Insider Profile
4 Followers
Steven Goldby, Director at Lifecore Biomedical, holds 73.14K shares in Lifecore Biomedical (Ticker: LFCR), holds 0.00 shares in Accelrys (Ticker: ~ACCL), holds 0.00 shares in Viracta Therapeutics (Ticker: VIRX).
Steven Goldby's Trading History
| LFCRLifecore Biomedical | May 28, 2019 | Director | Uninformative Buy | 39.64K | $469.17K | |
| VIRXViracta Therapeutics | ― | ― | ― | $0.00 | ||
| ~ACCLAccelrys | ― | ― | ― | ― |
You May Also Like
Steven Goldby insider profile FAQ
What is the percentage of profitable transactions made by Steven Goldby?
The percentage of profitable transactions made by Steven Goldby is 67%.
What is the average return per transaction made by Steven Goldby?
The average return per transaction made by Steven Goldby is 9.30%.
What stocks does Steven Goldby hold?
Steven Goldby holds: LFCR, ~ACCL, VIRX stocks.
What was Steven Goldby’s latest transaction?
Steven Goldby’s latest transaction was an Uninformative Buy of $39.64K.
What was Steven Goldby's most profitable transaction?
Steven Goldby’s most profitable transaction was an Informative Buy of LFCR stock on June 10, 2014. The return on the trade was 26.90%.
What is Steven Goldby's role in Lifecore Biomedical?
Steven Goldby's role in Lifecore Biomedical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
